Navigation Links
Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
Date:3/31/2009

SAN DIEGO, March 31 /PRNewswire-FirstCall/ --- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that its Board of Directors has appointed Michael Narachi as President and Chief Executive Officer of the Company, effective immediately. Narachi succeeds Eckard Weber M.D., Executive Chairman and Interim President and CEO.

"Michael brings nearly a quarter century of biotechnology and pharmaceutical experience in clinical development, commercialization, strategic business development and planning to Orexigen," said Eckard Weber, M.D., Executive Chairman and Interim President and CEO of Orexigen. "We are confident that his broad expertise will be instrumental as we focus on FDA approval of Contrave(R), exploring partnership opportunities and executing on broader business strategies."

As President and CEO, Narachi will see through the completion of the remaining three Phase 3 trials for Contrave (naltrexone sustained release (SR)/bupropion SR) and its NDA filing, which is on track for the first half of 2010. Narachi also will oversee the development of Empatic(TM) (zonisamide SR/bupropion SR), which is in the later stages of Phase 2 clinical development.

"I'm thrilled to join the Orexigen team and to have the opportunity to impact the treatment of obesity, a disease of epidemic proportions worldwide with a significant unmet need," said Narachi. "I believe in the Orexigen opportunity and, in particular, in the potential of this approach to help patients who suffer from obesity and its related co-morbidities."

Prior to joining Orexigen, Narachi, age 50, served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company and Executive Chairman of the Board of Naryx Pharma,
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
2. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
3. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
4. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
5. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
6. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. MRSA study suggests strategy shift needed to develop effective therapeutics
9. Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
10. MPM Capital Leads Investment in Proteon Therapeutics
11. Cell Therapeutics Reschedules Special Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Rolling Meadows, IL (PRWEB) May 27, 2015 ... the release of its SonarMD Platform, a ... engaging, monitoring and managing patients with chronic ... Lawrence Kosinski, MD, MBA, the application allows ... between visits through the ongoing use of ...
(Date:5/27/2015)... SmarterSkin, http://www.smarterskindermatology.com , is taking skin ... that makes it easier for patients to find skin care ... Dr. Sejal Shah is a cosmetic dermatologist based in New ... the test. This revolutionary DNA test uses 16 genetic markers ... , 1. Firmness and elasticity , 2. Glycation ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
(Date:5/27/2015)... May 27, 2015 Representatives from Classified ... year’s conference of the American Immigration Lawyers Association (AILA). ... National Resort. MCA’s booth is #404. , The annual ... Immigration Law.” MCAads.com, a regular AILA conference attendee, describes ... they welcome current clients to their booth and make ...
(Date:5/27/2015)... 27, 2015 National Healthcare ... award winning web development and interactive marketing ... the launch of its newly redesigned, custom ... National Healthcare Providers, is a physician owned ... the areas of Radiology, Anesthesiology, Emergency and ...
Breaking Medicine News(10 mins):Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:CRN International Names New Chief Financial Officer 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3
... reason not to eat pate de foie gras is discussed ... States, Washington DC in a forthcoming issue of the ... , Harmful proteins fragments known as amyloid fibrils associated with ... cells in Type II diabetes can be present in the ...
... Scientists at the University of Liverpool will launch a ... such as HIV and tuberculosis. , The Centre, which ... the Health Protection Agency, is one of 12 in ... for Health Research (NIHR) as part of the Government,s ...
... CHARLOTTE, N.C., Feb. 10 USHIFU, a worldwide ... invasive high intensity focused,ultrasound technologies, is pleased to ... consulting position of Chief Medical Officer. Dr.,Schoenberg is ... Urologic,Oncology who has authored more than 100 peer-reviewed ...
... Feb. 10 Erdman, A Cogdell Spencer,Company is ... Erdman,Place, has earned the U.S. Environmental Protection Agency,s ... energy efficiency,and environmental protection. America,s commercial buildings and ... of similar facilities for energy,efficiency may qualify for ...
... SAN DIEGO, Feb. 10 NuVasive, Inc. (Nasdaq: ... developing products for minimally disruptive surgical treatments for the ... & Chief Financial Officer, is scheduled to present at ... The Ritz-Carlton Hotel in Laguna Niguel, California on Tuesday, ...
... one-of-a-kind claims processing, business intelligence, and portal ... in the 21st-century healthcare marketplaceBURLINGTON, Mass., Feb. ... modern, enterprise-class software platform for healthcare payors, ... selected the HealthRules product suite as their ...
Cached Medicine News:Health News:Give the foie gras a miss 2Health News:Biomedical research center opens in Liverpool 2Health News:USHIFU Appoints Mark Schoenberg, M.D. Chief Medical Officer 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 3Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 4Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 2Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 3Health News:Mississippi Administrative Services Chooses the HealthRules(R) Product Suite from HealthEdge(R) to Address Next-Generation Business Needs 2
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)... May 27, 2015 In a new ... Canadian International Pharmacy Association (CIPA) found continued ... licensed Canadian pharmacies. Approximately 64% of respondents purchase some ... a non-U.S. pharmacy due to costs of filling ... under their insurance plan.   Many news ...
(Date:5/27/2015)... May 27, 2015  Genomic Health, Inc. (Nasdaq: GHDX ... Officer and Chief Financial Officer, will present at the Jefferies ... on Monday, June 1 at 8:30 a.m. Eastern ... archived webcast of the presentation, go to the  Investor Relations ... Please connect to the web site at least 15 minutes ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... , Feb. 17 /PRNewswire / -- SI-BONE, Inc. ( ... use of a minimally invasive surgical device to treat sacroiliac (SI) ... joined the Company,s Medical Advisory Board.  Drs. Frank M. Phillips ... join Drs. Steven R. Garfin (chair), Mark ...
... SAN DIEGO , Feb. 17 Hollis-Eden Pharmaceuticals, ... its name to Harbor BioSciences, Inc. and that its ticker symbol ... 2010 . The company also received a new CUSIP number (41150V ... begin 2010 with a targeted business strategy focused on attaining proof-of-concept ...
Cached Medicine Technology:Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 2Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 3Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 4Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 2Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 3
... The SYNCHRON CX9 ALX system is ... time-consuming manual processes by as much as ... lower your total costs. Featuring the AccuSense® ... and an expanded test menu, the CX9 ...
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... This user-friendly instrument is ... Protein analyzer for the ... is a well established ... results for a wide ...
Medicine Products: